FDA Guidance for Industry: Quality Considerations for Continuous Manufacturing

Title:
FDA Guidance for Industry: Quality Considerations for Continuous Manufacturing
Origin/Publisher:

FDA

Content:
This guidance provides information regarding FDA’s current thinking on the quality considerations for continuous manufacturing of small molecule, solid oral drug products that are regulated by the Center for Drug Evaluation and Research (CDER).

Go back